LÖFGREN’S SYNDROME: ASSESSMENT OF OUTCOMES


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The clinical features and outcomes of erythema nodosum were studied in patients with Löfgren’s syndrome.

全文:

受限制的访问

作者简介

N. Savushkina

V.A. Nasonova Research Institute of Rheumatology

Email: savushkinanm@mail.ru

O. Egorova

V.A. Nasonova Research Institute of Rheumatology

Candidate of Medical Sciences

S. Glukhova

V.A. Nasonova Research Institute of Rheumatology

Candidate of Medical Sciences

S. Radenska-Lopovok

V.A. Nasonova Research Institute of Rheumatology

B. Belov

V.A. Nasonova Research Institute of Rheumatology

参考

  1. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics // Dis. Mon. - 2009; 55: 649-60.
  2. Hanno R., Callen J. Sarcoidosis: a disorder with prominent cutaneous features and their interrelationship with systemic disease // Med. Clin. North. Am. - 1980; 64: 847-66.
  3. Mana J., Marcoval J. Skin manifestations of sarcoidosis // Presse Med. -2012; 41: 355-74.
  4. Parrish S., Turner J. Diagnosis of sarcoidosis // Dis. Mon. - 2009; 55: 693-703.
  5. Mana J., Gomez-Vaquero C., Montero A. et al. Lofgren’s syndrome revisited: a study of 186 patients // Am. J. Med. - 1999; 107: 240-5.
  6. Löfgren S., Lundbäck H. The bilateral hilar lymphoma syndrome. A study of the relation to age and sex in 212 cases // Acta Med. Scand. - 1952; 142: 259-64.
  7. Mana J., Marcoval J. Erythema nodosum // Clin. Dermatol. - 2007; 25: 288-94.
  8. Mana J., Marcoval J., Graells J. et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease // Arch. Dermatol. - 1997; 133: 882-8.
  9. Paramothayan N., Jones P. Corticosteroids for pulmonary sarcoidosis // Cochrane Database Syst. Rev. - 2000; 2: CD001114.
  10. Hunninghake G., Costabel U., Ando M. et al. ATS/ ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders // Sarcoidosis Vasc. Diffuse Lung Dis. - 1999; 16 (2): 149-73.
  11. Чучалин А.Г., Авдеев С.Н., Баранова О.П. и др. Диагностика и лечение саркоидоза (Федеральные согласительные клинические рекомендации) / Минздрав России. Российское респираторное общество, 2014; с. 36-9.
  12. Ungprasert P., Carmona E., Utz J. et al. Epidemiology of Sarcoidosis 19462013: A Population-Based Study // Mayo Clin. Proc. - 2016; 91 (2): 183-8.
  13. Tejera Segura B., Holgado S., Mateo L. et al. Löfgren syndrome: A study of 80 cases // Medicina Clinica. - 2014; 143 (4): 166-9.
  14. Mana J., Salazar A., Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases // Respiration. - 1994; 61 (4): 219-25.
  15. Takada K., Ina Y., Noda M. et al. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis // J. Clin. Epidemiol. - 1993; 46 (4): 359-66.
  16. Визель И.Ю., Шмелев Е.И., Баранова О.П. и др. Мультицентровой ретроспективный анализ состояния больных саркоидозом с 10-летним интервалом наблюдения // Клиническая медицина. - 2014; 92 (6): 28-34.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2016
##common.cookie##